Tag Archive | "Genentech"

Genentech and Human Longevity in genome sequencing pact

Tags: , ,

Human Longevity announced a multi-year agreement with Genentech to conduct whole genome sequencing of tens of thousands of de-identified samples Read the full story

NewLink Genetics strike $1 billion pharma deal with Genentech

Tags: , ,

NewLink Genetics has inked a pharma deal potentially worth $1 billion with Genentech for the development of NLG919, NewLink's IDO pathway inhibitor. Read the full story


Tags: ,

Genentech is the biotech subsidiary of Roche. Read the full story

Genentech biotech deals Arrayit for drug discovery tool

Tags: , , ,

Genentech has entered into biotech deals with Arrayit to purchase a drug discovery tool for $138,000. Read the full story

Genentech pharma deals Biologics for Tarceva distribution

Tags: , , ,

Biologics pharma deals Genentech to be part of a limited group of specialty pharmacies authorized to distribute Tarceva. Read the full story

Genentech pharma delas Immunocore for $330 million cancer and viral targets

Tags: , , ,

Immunocore has entered into pharma deals involving a collaborative R&D and licensing agreement with Genentech for the discovery and development of multiple novel cancer targets using Immunocore’s ImmTAC technology. Read the full story

Partnering with Genentech: Pioneering partnerships

Tags: , ,

Genentech is a top biotech company, subsidiary of Swiss pharma giant Roche, and active in partnering, licensing in, biotech healthcare Read the full story

Partnering with Roche: Think Roche, Think Partnering

Tags: , , , ,

Roche is a top pharma company active in partnering, licensing and M&A in pharmaceuticals and biotechology Read the full story

Roche / Genentech: Partnering activity 2005-2013

Tags: , , ,

Roche announced over 375 partnering / licensing deals since 2005, with over 24 deals in 2012 alone, whilst Genentech announced over 98 partnering / licensing deals since 2005 Read the full story

Roche: Company profile

Tags: , , ,

Roche, a top pharmaceutical/biotechnology company, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years Read the full story